KIORA PHARMACEUTICALS INC (KPRX:NASDAQ)

$2.79 0.09 (3.3333%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 83

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) News Sources

Kiora Pharmaceuticals Reports Third Quarter 2025 Results; Company Advances Pipeline with Two Actively Enrolling Phase 2 Clinical Trials for Retinal Diseases

07-11-2025

yahoo.com

Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds

01-12-2025

yahoo.com

Retinal Disease Expert Dr. Taiji Sakamoto Joins Kiora Pharmaceuticals' Scientific Advisory Board

27-01-2026

yahoo.com

Kiora Pharmaceuticals to Present at Oppenheimer's 36th Annual Healthcare Life Sciences Conference

19-02-2026

yahoo.com

Kiora Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Results; Company Advances Retinal Disease Pipeline with Two Active Phase 2 Clinical Trials

25-03-2026

yahoo.com

Kiora Pharmaceuticals Announces Management Team Changes

02-04-2026

yahoo.com

Kiora Pharmaceuticals Announces Private Placement for Up to $24 Million Led by Perceptive Advisors

07-04-2026

yahoo.com

Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline

09-04-2026

yahoo.com

Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway

14-04-2026

yahoo.com

Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update

08-05-2026

yahoo.com

KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) Sentiment Trend

0 25 50 75 100 91 84 85 86 91 83 74 63 87 91 07-11-2025 01-12-2025 27-01-2026 19-02-2026 25-03-2026 02-04-2026 07-04-2026 09-04-2026 14-04-2026 08-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) FAQs

toggle

What is the current price of KIORA PHARMACEUTICALS INC (KPRX:NASDAQ)?

The current price of KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) is $2.79.


toggle

KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) absolute price change since previous trading day?

The absolute price change of KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) since the previous trading day is $0.09.


toggle

KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) percentage price change since previous trading day?

The percentage price change of KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) since the previous trading day is 3.3333%.


toggle

What is the most recent average sentiment score for KIORA PHARMACEUTICALS INC (KPRX:NASDAQ)?

The most recent average sentiment score for KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) is 83 out of 100.


toggle

What is the most recent average sentiment for KIORA PHARMACEUTICALS INC (KPRX:NASDAQ)?

The most recent sentiment for KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) is .


SEC-8K** Filing Available For KIORA PHARMACEUTICALS INC (KPRX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.